Condition: Cluster Headache · Sponsor: Norwegian University of Science and Technology
Cluster headache is a primary headache condition characterized by clusters of one-sided, high-intensity pain attacks. The headache may be episodic or chronic. Treatment options are limited and their effects unsatisfactory. An important nerve pathway involved in the pain attacks has a switching station at the sphenopalatine ganglion (SPG) located in the depth of the facial bones. SPG is a known therapy target for cluster headache. The area can be identified on CT images, but is difficult to access due to its location. Thus, the Multiguide navigation system has been developed to enable precise delivery of the drugs that target SPG activity. In Trondheim, two phase 1 / Phase 2 study have been carried out using botulinum toxin A (Botox®) against SPG in patient with chronic cluster headache and chronic migraine. The results indicate that such a treatment strategy is safe and beneficial. The current study is a randomized, placebo-controlled, triple-blinded study to investigate whether precise single-injection of botulinum toxin A reduces the frequency of attacks in chronic cluster headache .
This description comes directly from the study's public registry record.
Tore Wergeland Meisingset, md phd · +47 728 21 335 · tore.w.meisingset@ntnu.no
Erling Tronvik, md phd · erling.tronvik@ntnu.no
Always discuss trial participation with your own doctor first.
| Praxisklinik Ulmenhof | Hamburg, Germany | Recruiting |
| Fondazione IRCCS Istituto Neurologico Carlo Besta (CBNI) | Milan, Italy | Recruiting |
| St Olavs Hospital | Trondheim, Norway | Recruiting |
| Department of Neurology, University Clinic Hospital. Catholic University of Valencia | Valencia, Spain | Recruiting |
| National Hospital of Neurology and Neurosurgery, University College of London | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03944876